The role of the clinician in the multi-omics era: are you ready?

Since Garrod’s first description of alkaptonuria in 1902, and newborn screening for phenylketonuria introduced in the 1960s, P4 medicine (preventive, predictive, personalized, and participatory) has been a reality for the clinician serving patients with inherited metabolic diseases. The era of high-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Inherit Metab Dis
Main Authors: van Karnebeek, Clara D. M., Wortmann, Saskia B., Tarailo-Graovac, Maja, Langeveld, Mirjam, Ferreira, Carlos R., van de Kamp, Jiddeke M., Hollak, Carla E., Wasserman, Wyeth W., Waterham, Hans R., Wevers, Ron A., Haack, Tobias B., Wanders, Ronald J.A., Boycott, Kym M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Netherlands 2018
Assuntos:
Phenomics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959952/
https://ncbi.nlm.nih.gov/pubmed/29362952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10545-017-0128-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados